IGC Pharma (IGC) Capital Expenditures (2011 - 2025)
IGC Pharma (IGC) reported Capital Expenditures of $29000.0 for Q3 2025, little changed year-over-year from $29000.0 in Q3 2024, and up 262.5% quarter-over-quarter from $8000.0 in Q2 2025.
IGC Pharma (IGC) Capital Expenditures (2011 - 2025) Analysis & Trends
IGC Pharma (IGC) has 14 years of Capital Expenditures data on file, last reported at $29000.0 in Q3 2025.
- Capital Expenditures for Q3 2025 came in at $29000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2025 was $82000.0 (down 45.33% YoY), and the FY2026 annual result was $1000.0, down 99.11% from the prior year.
- Capital Expenditures climbed to $29000.0 in Q3 2025 per IGC's latest filing, from $8000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $582000.0 in Q4 2022 and troughed at -$404000.0 in Q3 2022.
- A 5-year average of $48526.3 and a median of $29000.0 in 2024 frame the typical range for Capital Expenditures.
- On a YoY basis, Capital Expenditures climbed as much as 2055.56% in 2022 and fell as far as 1362.5% in 2022.
- A 5-year view of Capital Expenditures shows it stood at $27000.0 in 2021, then soared by 2055.56% to $582000.0 in 2022, then sank by 88.32% to $68000.0 in 2023, then sank by 60.29% to $27000.0 in 2024, then increased by 7.41% to $29000.0 in 2025.
- Business Quant data shows IGC's Capital Expenditures at $29000.0 in Q3 2025, $8000.0 in Q2 2025, and $18000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -63,220.27 |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 29,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 38,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Sep 30, 2023 | 35,000.00 |
| Sep 30, 2023 | 35,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 20,000.00 |